Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis

Phase: EARLY_PHASE1 | Sponsor: Johns Hopkins University | Compound: Psilocybin

Status

recruiting

Institution

Johns Hopkins University

Start date

2025-04-09

End date

2026-07-01

Registry ID

NCT06656702

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.